Influence of Risk Factors and Diabetic Complications on Peripheral Nerve Function in Type 2 Diabetes Mellitus

1. Boulton AJ, Vinik AI, Arezzo JC et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005; 28:956-962.10.2337/diacare.28.4.95615793206Search in Google Scholar

2. Llewelyn JG, Tomlinson DR, Thomas PK. Diabetic Neuropathies. In: Dck PJ, Thomas PK [Eds]. Peripheral Neuropathy, Fourth Edition, Elsevier Saunders, Philadelphia 2005: 1951-1991.10.1016/B978-0-7216-9491-7.50088-0Search in Google Scholar

3. Vinik AI, Maser RE, Mitchell BD et al. Diabetic autonomic neuropathy. Diabetes Care 2003; 26: 1553-1579.10.2337/diacare.26.5.155312716821Search in Google Scholar

4. Gibbons CH, Freeman R, Veves A. Diabetic neuropathy: a cross-sectional study of the relationship among test of neurophysiology. Diabetes Care 2010; 33: 2629-2634.10.2337/dc10-0763299220320805259Search in Google Scholar

5. Stratton IM, Adler AI, Neil HA et al on behalf of the UKPDS Group. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 2000; 32: 405-12.10.1136/bmj.321.7258.4052745410938048Search in Google Scholar

6. American Diabetes Association, American Academy of Neurology. Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes Care 1988; 11: 592-597.10.2337/diacare.11.7.5923060328Search in Google Scholar

7. Kimura J. Principles and variations of nerve conduction studies. In: Kimura J [Ed]. Electrodiagnosis in Diseases of the Nerve and Muscle: Principles and practice, Oxford University Press, New York 2013: 91-129.10.1093/med/9780199738687.001.0001Search in Google Scholar

8. Ewing DJ, Martyn CN, Young RJ et al. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985; 8: 491-498.10.2337/diacare.8.5.4914053936Search in Google Scholar

9. Spallone V, Ziegler D, Freeman R et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis and management. Diabetes Metab Res Rev 2011; 27: 639-653.10.1002/dmrr.123921695768Search in Google Scholar

10. Ziegler D, Laux G, Dannehl K et al. Assessment of cardiovascular autonomic function: age- related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med 1992; 9: 166-175.10.1111/j.1464-5491.1992.tb01754.x1563252Search in Google Scholar

11. Tesfaye S, Boulton AJ, Dyck PJ et al. Diabetic Neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33: 2285-2293.10.2337/dc10-1303Search in Google Scholar

12. Wendelhag I, Gustavsson T, Suurkula M et al. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of computerized image analyzing system. Clin Physiol 1991; 11: 565-577.10.1111/j.1475-097X.1991.tb00676.xSearch in Google Scholar

13. Dyck PJ, Carter RE, Litchy WJ. Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathy. Muscle Nerve 2011; 44: 340-345.10.1002/mus.22074Search in Google Scholar

14. Karsidag S, Morali S, Sargin M et al. The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus. Diabetes Res Clin Pract 2005; 67: 211-219.10.1016/j.diabres.2004.07.017Search in Google Scholar

15. Said G. Diabetic neuropathy: an update. J. Neurol 1996; 243: 431-440.Search in Google Scholar

16. Thomas PK. Diabetic neuropathy: mechanism and future treatment options. J Neurol Neurosurg Psychiatry 1999; 67: 277-9.10.1136/jnnp.67.3.277Search in Google Scholar

17. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabet Metab 1977; 3: 173-182.Search in Google Scholar

18. Tesfaye S, Stevens LK, Stephenson JM et al. Prevalence of diabetic peripheral neuropathy and its relation with glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996; 39: 1377-1384.10.1007/s001250050586Search in Google Scholar

19. Valensi P, Giroux C, Seeboth-Ghalayini B et al. Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control and vascular factors. J Diabetes Complications 1997; 11: 27-34.10.1016/S1056-8727(95)00086-0Search in Google Scholar

20. Tkac I, Bril V. Glycemic control is related to the electrophysiological severity of diabetic peripheral sensorimotor polyneuropathy. Diabetes Care 1998; 21: 1749-1752.10.2337/diacare.21.10.1749Search in Google Scholar

21. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.10.1016/S0140-6736(98)07019-6Search in Google Scholar

22. Partanen J, Niskanen L, Lehtinen J et al. Natural history of peripheral neuropathy in patients with non-insulin dependent diabetes. N Engl J Med 1995; 333: 89-94.10.1056/NEJM1995071333302037777034Search in Google Scholar

23. Dyck PJ, Davies JL, Wilson DM et al. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 1999; 22: 1479-1486.10.2337/diacare.22.9.147910480512Search in Google Scholar

24. Lehtinen JM, Niskanen L, Hyvonen K et al. Nerve function and its determinants in patients with newly-diagnosed type 2 (non-insulindependent) diabetes mellitus and in control subjects - 5-year follow-up. Diabetologia 1993; 36: 68-72.10.1007/BF003990968436256Search in Google Scholar

25. Brownlee M. Diabetic complications: pathobiology of hyperglycemic damage and potential impact on treatment. In: Thornalley PJ, Kempler P [Eds]. Complications of diabetes mellitus: pathophysiology and pathogenetically-based treatment options, Georg Thieme Verlag KG Stuttgart 2009: 1-8.Search in Google Scholar

26. Hammes HP. Diabetic nerve, vascular and organ damage from the pathogenetic key to new therapeutic approaches. In: Rett K [Ed]. Better chances for nerves and vessels, Georg Thieme Verlag KG Stuttgart 2011: 9-19.Search in Google Scholar

27. Toyry JP, Partanen JV, Niskanen LK et al. Divergent development of autonomic and peripheral somatic neuropathies in NIDDM. Diabetologia 1997; 40: 953-958.10.1007/s0012500507739267991Search in Google Scholar

28. Pop-Busui R, Evans GW, Gerstein HC , Fonseca V, Fleg JL, Hoogwerf et al. Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. Diabetes Care 2010; 33:1578-1584.10.2337/dc10-0125289036220215456Search in Google Scholar

29. Calles-Escandon J, Lovato LC, Simons-Morton DG, Kendall D, Pop-Busui R, Cohen R et al. Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 2010; 33: 721-727.10.2337/dc09-1471284501220103550Search in Google Scholar

30. Papanas N, Symeonidis G, Mavridis G et al. Ankle-Brachial index: a surrogate marker of microvascular complications in type 2 diabetes mellitus? Int Angiol 2007; 26: 253-257.Search in Google Scholar

31. Brooks B, Dean R, Patel S, Wu B, Molyneaux L, Yue DK. TBI or not TBI: that is the question. Is better to measure toe pressure than ankle pressure in diabetic patients? Diabet Med 2001; 18: 528-532.Search in Google Scholar

32. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical Cardiovascular events wit Carotid Intima -Media Thickness. A systematic Review and Meta-Analysis. Circulation 2007; 115: 459-467. 10.1161/CIRCULATIONAHA.106.62887517242284Search in Google Scholar